CLINICAL TRIAL: A STUDY OF CREATINE IN SUBJECTS WITH TREATED PARKINSON'S DISEASE

临床试验：肌酸对帕金森病治疗对象的研究

• 批准号: 8167236
• 负责人: ANDREW FEIGIN
• 金额: $ 1.91万
• 依托单位: FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-04-01 至 2011-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8167236
• 关键词: Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Creatine; Funding; Gait; Grant; Impaired cognition; Institution; Measures; Medical; Parkinson Disease; Placebos; Research; Research Personnel; Resources; Source; United States National Institutes of Health; primary outcome

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This five year study will compare the primary outcome as measured by the Parkinson's disease functioning, ambulatory gait, cognitive impairment and global functioning in the creatine group versus the placebo group against a background of dopaminergic therapy and best medical practice.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 这项为期五年的研究将在多巴胺能治疗和最佳医疗实践的背景下，比较肌酸组与安慰剂组的帕金森病功能、行走步态、认知障碍和整体功能的主要结果。